Markets:

Overview

News

Currencies

International

Treasuries

Vertex Pharmaceuticals (NQ:VRTX)

488.74 +4.71 (+0.97%)

Streaming Delayed Price Updated: 10:44 AM EDT, Aug 7, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Vertex Pharmaceuticals

< Previous 1 2

...

25 26 27 28 29 30 31 32 33

...

75 76 Next >

SLB, First Solar And 2 Other Stocks Insiders Are Selling ↗

May 23, 2024

Via Benzinga

Walmart, Vertex Pharmaceuticals And More On CNBC's 'Final Trades' ↗

May 23, 2024

Walmart Inc. reported a "really strong" quarter, with e-commerce sales surging 21%. Adjusted EPS was 60 cents.

Via Benzinga

The 2030 Millionaire’s Club: 3 Biotech Stocks to Buy Now ↗

May 23, 2024

With interest cuts on the horizon, it's a prime time to consider these high-risk-high-reward biotech stocks to buy.

Via InvestorPlace

Vertex to Participate in Upcoming June Investor Conferences

May 22, 2024

From Vertex Pharmaceuticals Incorporated

Via Business Wire

Should you consider NASDAQ:VRTX for quality investing? ↗

May 22, 2024

VERTEX PHARMACEUTICALS INC (NASDAQ:VRTX) Exhibits Quality Stock Traits. Here's Why.

Via Chartmill

Vertex Pharmaceuticals's Options Frenzy: What You Need to Know ↗

May 15, 2024

Via Benzinga

A Closer Look at Vertex Pharmaceuticals's Options Market Dynamics ↗

May 08, 2024

Via Benzinga

Smart Money Is Betting Big In VRTX Options ↗

May 06, 2024

Via Benzinga

Halozyme Therapeutics Stock Earns IBD Stock Rating Upgrade, Hitting 80-Plus RS Rating ↗

May 16, 2024

On Thursday, biotech Halozyme Therapeutics stock had its Relative Strength (RS) Rating upgraded to 84, up from 80 a day earlier.

Via Investor's Business Daily

Is CRISPR Stock Going to $95? 1 Wall Street Analyst Thinks So. ↗

May 15, 2024

How much would you pay for a stock that might earn $25 a year in six years?

Via The Motley Fool

Jennifer Schneider Elected to Vertex Board of Directors

May 15, 2024

From Vertex Pharmaceuticals Incorporated

Via Business Wire

Pfizer, Freeport-McMoRan, Vertex Pharmaceuticals And A Major Tech Stock On CNBC's 'Final Trades' ↗

May 15, 2024

Pfizer is looking to build on the success of its COVID-19 vaccine rollout by introducing a direct-to-consumer medicines platform.

Via Benzinga

Catalyst Pharmaceuticals Stock Clears Technical Benchmark With 83 RS Rating ↗

May 14, 2024

On Tuesday, Catalyst Pharmaceuticals stock hit a key technical milestone, with its Relative Strength Rating climbing to 83 from 79.

Via Investor's Business Daily

3 Cheap Biotech Stocks to Buy Now: May 2024 ↗

May 14, 2024

Many of these cheap biotech stocks are on their way to achieving FDA approval for their drugs to enter the market.

Via InvestorPlace

Here's How Much You Would Have Made Owning Vertex Pharmaceuticals Stock In The Last 10 Years ↗

May 14, 2024

Via Benzinga

Vertex Pharmaceuticals Is Racing Towards a New Blockbuster: Why the Stock Is a Smart Buy ↗

May 12, 2024

The biotech's shares dropped following its latest quarterly update, but that shouldn't matter to long-term investors.

Via The Motley Fool

2 Unbelievable Growth Stocks You Can Buy and Hold for the Next Decade ↗

May 12, 2024

These companies are raking in profits at astonishing clips.

Via The Motley Fool

Stock Market Moves Toward Highs; Arista, Toast, Palantir Key Earnings Movers: Weekly Review ↗

May 10, 2024

Big earnings winners and losers continued.

Via Investor's Business Daily

Will the Biotech Sector Shift From Lagger to Leader?

May 10, 2024

The biotech sector has experienced a significant rally after bouncing off uptrend support and is now consolidating near major SMAs.

Via MarketBeat

Topics ETFs

Investors seeking growth at a reasonable cost should explore NASDAQ:VRTX. ↗

May 08, 2024

While growth is established for NASDAQ:VRTX, the stock's valuation remains reasonable.

Via Chartmill

5 Reasons Vertex Pharmaceuticals Is a Screaming Buy on the Dip ↗

May 08, 2024

New drugs in development and a lack of significant patent cliffs ahead make this a great pharma stock to buy now and hold over the long run.

Via The Motley Fool

Topics Intellectual Property

Markets In A Minute - "A Lack Of Further Progress" ↗

May 07, 2024

May's FOMC meeting left the Fed Funds Rate unchanged. JOLTS showed fewer job openings with increased layoffs. April's job report disappointed, adding only 175k jobs and seeing higher unemployment....

Via Talk Markets

Topics Economy Workforce

10 Health Care Stocks With Whale Alerts In Today's Session ↗

May 07, 2024

Via Benzinga

US Stocks Eye Fourth Positive Session Despite Hawkish Fed Remarks; Disney, Palantir Tumble; Treasury Yields Fall: What's Driving Markets Tuesday? ↗

May 07, 2024

Wall Street experienced a quiet session during morning trading on Tuesday, influenced by a lack of significant economic data and minimal updates on earnings from major large-cap companies.

Via Benzinga

Topics Economy

VRTX Stock Earnings: Vertex Pharmaceuticals Beats EPS, Beats Revenue for Q1 2024 ↗

May 06, 2024

VRTX stock results show that Vertex Pharmaceuticals beat analyst estimates for earnings per share and beat on revenue for the first quarter of 2024.

Via InvestorPlace

Vertex Pharmaceuticals (VRTX) Q1 2024 Earnings Call Transcript ↗

May 06, 2024

VRTX earnings call for the period ending March 31, 2024.

Via The Motley Fool

Topics Earnings

Vertex Beats First-Quarter Expectations, But Shares Stay Flat On Reiterated Outlook ↗

May 06, 2024

Vertex Pharmaceuticals beat first-quarter sales and earnings forecasts.

Via Investor's Business Daily

Vertex Reports First Quarter 2024 Financial Results

May 06, 2024

From Vertex Pharmaceuticals Incorporated

Via Business Wire

3 Biotech Stocks to Double Your Money in the Next 24 Months ↗

May 06, 2024

The biotech sector offers significant potential for growth. These 3 biotech stocks to double your money are noteworthy candidates.

Via InvestorPlace

3 No-Brainer Stocks to Buy in May ↗

May 05, 2024

These great stocks are great picks for investors as spring winds down.

Via The Motley Fool

< Previous 1 2

...

25 26 27 28 29 30 31 32 33

...

75 76 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.